EP3350248A1 - Polymération anionique de lactames - Google Patents

Polymération anionique de lactames

Info

Publication number
EP3350248A1
EP3350248A1 EP16762808.0A EP16762808A EP3350248A1 EP 3350248 A1 EP3350248 A1 EP 3350248A1 EP 16762808 A EP16762808 A EP 16762808A EP 3350248 A1 EP3350248 A1 EP 3350248A1
Authority
EP
European Patent Office
Prior art keywords
mixture
group
alkyl
component
unsubstituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP16762808.0A
Other languages
German (de)
English (en)
Inventor
Philippe Desbois
Rene ARBTER
Bernd Bruchmann
Robert Stein
Frank THIELBEER
Rolf Muelhaupt
Tina ANDRAE
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF SE
Original Assignee
BASF SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BASF SE filed Critical BASF SE
Publication of EP3350248A1 publication Critical patent/EP3350248A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G69/00—Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
    • C08G69/02—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids
    • C08G69/08—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids derived from amino-carboxylic acids
    • C08G69/14—Lactams
    • C08G69/16—Preparatory processes
    • C08G69/18—Anionic polymerisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D223/08—Oxygen atoms
    • C07D223/10—Oxygen atoms attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D263/06—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms

Definitions

  • the present invention relates to a process for the preparation of a polyamide (P) by reacting a mixture (M), the at least one lactam (component (A)), at least one catalyst (component (B)), at least one activator (Component (C)) and at least one oxazolidine derivative (Component (D)). Moreover, the present invention relates to the mixture (M) and the use of an oxazolidine derivative for increasing the crystallization rate of a polyamide (P).
  • the present invention further relates to the use of an oxazolidine derivative in a polyamide (P) for producing a molded article of the polyamide (P) for reducing the mold release time, and to the use of an oxazolidine derivative for removing water from a reaction mixture (RM ).
  • Polyamides are generally semicrystalline polymers, which are industrially of particular importance, since they are characterized by very good mechanical properties. In particular, they have a high strength, rigidity and toughness, good chemical resistance and a high abrasion resistance and tracking resistance. These properties are particularly important for the production of injection molded parts. High toughness is particularly important for the use of polyamides as packaging films. Due to their properties, polyamides are used industrially for the production of textiles such as fishing lines, climbing ropes and carpets. In addition, polyamides find use for the production of dowels, screws and cable ties. In addition, polyamides are used as paints, adhesives and coating materials.
  • the production of moldings of the polyamides is advantageously carried out by polymerization of the corresponding monomers directly in the mold, starting from monomer powder, wherein the polymerization is started in situ. In general, only heating to a temperature above the melting point of the monomer is required. Heating above the melting point of the polymer, which is usually higher than the melting point of the monomer, is generally not required.
  • DE 1 495 132 describes, for example, the polymerization of a lactam mixture which may contain an acid chloride, an isocyanate or an isocyanate releaser, by adding an alkali lactamate solution containing primary and / or secondary mono- and / or polyamines.
  • the alkali metal lactamate solution may also contain an acid chloride, an isocyanate or an isocyanate releaser.
  • DE 4 002 260 describes the anionic polymerization of a caprolactam mixture, which may contain acid chlorides, isocyanates, substituted ureas, urethanes or guanidines, by adding a catalyst solution comprising a lactam, an alkali metal and poly-C 1 -C 4 -alkylene glycol and a primary and / or secondary mono- and / or polyamine.
  • a catalyst solution comprising a lactam, an alkali metal and poly-C 1 -C 4 -alkylene glycol and a primary and / or secondary mono- and / or polyamine.
  • US 3,216,977 describes the preparation of a polyamide from a lactam. In this case, a lactam is reacted with an anionic catalyst and a substituted 2-methylene-1, 3-oxazolidine-4,5-dione as cocatalyst.
  • the US 3,410,833 also describes a process for the preparation of polyamides.
  • a lactam is reacted in the presence of an anionic catalyst and a cocatalyst, which is prepared from amides and oxalyl chloride.
  • the cocatalyst is, for example, N-phenyl-2-methylene-oxazolidine-4,5-dione or N-methyl-2-benzylidene-oxazolidine-4,5-dione.
  • EP 0 786 486 describes a liquid multicomponent system for carrying out an anionic lactam polymerization.
  • the liquid multicomponent system contains a liquid solvating component, a catalyst and an activator.
  • the solvating component is selected, for example, from lactams, ureas, carboxylic esters, polyether esters, sterically hindered phenols, phenol esters, N-alkylated amines and alkyl oxazolines.
  • the solvating component is preferably a sterically hindered phenol, a phenol ester or a sterically hindered phenol ester.
  • a disadvantage of the processes described in the prior art is that the polymerization of the lactam must take place in the absence of water and oxygen.
  • EP 0 786 486 describes that phenolic phosphoric esters must additionally be used as scavengers for residual oxygen.
  • the polyamides prepared by the processes described in the prior art often have a high residual monomer content and the production of moldings requires long cycle times. In addition, the moldings are often bad to remove from the molds.
  • the object underlying the present invention is therefore to provide a process for the preparation of polyamides, which does not or only to a reduced extent have the disadvantages of the processes as described in the prior art.
  • This object is achieved by a process for the preparation of a polyamide (P) by reacting a mixture (M) containing the components
  • (D) contains at least one oxazolidine derivative.
  • the mixture (M) has a lower moisture sensitivity. Even mixtures (M) with a relatively high water content of, for example, 700 ppm can be reactivated with the oxazolidine derivative according to the invention, so that a conversion to the polyamide (P) is also possible for these mixtures (M).
  • shrinkage time of a molded article of the polyamide (P) produced with the mixture (M) according to the invention is markedly reduced, so that faster removal from the mold (ie faster removal of the molded article from a mold) is possible. This results in shorter cycle times in the production of moldings from the polyamide (P).
  • shrinkage time is also referred to as "release time.”
  • shrinkage time and release time are therefore used interchangeably in the context of the present invention and have the same meaning.
  • the removal of the molded article from the mold is not only faster possible with the mixture (M) according to the invention, but the molded article is also easier to remove from the mold.
  • the use of the oxazolidine derivative results in an increase in the crystallization rate of the polyamide (P) and an increase in the crystallization temperature of the polyamide (P). It is also advantageous that some of the properties of the polyamide (P) prepared according to the invention are almost identical to the physical properties of polyamides prepared by other processes described in the prior art.
  • the polyamide (P) prepared according to the invention has the same density and behavior in dynamic mechanical analysis (DMA) as polyamides obtainable by methods described in the prior art. The method according to the invention will be explained in more detail below.
  • the mixture (M) contains the components (A) at least one lactam, (B) at least one catalyst, (C) at least one activator and (D) at least one oxazolidine derivative.
  • the present invention thus also relates to a mixture (M) which comprises the components
  • (D) contains at least one oxazolidine derivative.
  • the mixture (M) may contain the components (A) to (D) in any amounts. For example, it contains in the range from 75 to 99.7% by weight of component (A), in the range from 0.1 to 5% by weight of component (B), in the range from 0.1 to 10% by weight. % of component (C) and in the range from 0.1 to 10% by weight of component (D), in each case based on the sum of the percentages by weight of components (A) to (D), preferably based on the total weight of the mixture ( M).
  • the mixture contains (M) in the range of 85 to 99.1 wt .-% of component (A), in the range of 0.2 to 3 wt .-% of component (B), in the range of 0.5 to 5 wt .-% of component (C) and in the range of 0.2 to 7 wt .-% of component (D), each based on the sum of the weight percent of components (A) to (D), preferably based on the Total weight of the mixture (M).
  • M Total weight of the mixture
  • the mixture contains (M) in the range of 91 to 98.2 wt .-% of component (A), in the range of 0.3 to 1 wt .-% of component (B), in the range of 1 to 3 Wt .-% of component (C) and in the range of 0.5 to 5 wt .-% of component (D), in each case based on the sum of the weight percent of components (A) to (D), preferably based on the total weight the mixture (M).
  • M in the range of 91 to 98.2 wt .-% of component (A), in the range of 0.3 to 1 wt .-% of component (B), in the range of 1 to 3 Wt .-% of component (C) and in the range of 0.5 to 5 wt .-% of component (D), in each case based on the sum of the weight percent of components (A) to (D), preferably based on the total weight the mixture (M).
  • the present invention thus also provides a process in which the mixture (M) is in the range from 75 to 99.7% by weight of component (A), in the range from 0.1 to 5% by weight of component ( B), in the range of 0, 1 to 10 wt .-% of Component (C) and in the range of 0, 1 to 10 wt .-% of component (D), based on the total weight of the mixture (M).
  • the mixture (M) may additionally contain at least one filler. Suitable fillers are known to the person skilled in the art.
  • At least one filler is understood to mean both exactly one filler and one mixture of two or more fillers.
  • the at least one filler is, for example, selected from the group consisting of kaolin, chalk, wollastonite, talc, calcium carbonate, silicates, titanium dioxide, zinc oxide, graphite, glass beads, carbon nanotubes, carbon black, sheet silicates, alumina, graphene, boron fibers, glass fibers, carbon fibers, silica fibers , 15 ceramic fibers, basalt fibers, aramid fibers, polyester fibers, nylon fibers, polyethylene fibers, wood fibers, flax fibers, hemp fibers and sisal fibers.
  • the mixture (M) contains, for example, in the range of 0, 1 to 90 wt .-%, preferably in the range of 1 to 50 wt .-% and particularly preferably in the range of 2 to 20 30 wt .-% of the at least one filler, based on the total weight of the mixture (M).
  • the mixture (M) may further contain additives.
  • Suitable additives are known to the person skilled in the art and are selected, for example, from the group comprising stabilizers, dyes, antistatics, filling oils, surface improvers, siccatives, mold release agents, release agents, antioxidants, light stabilizers, thermoplastic polymers, lubricants, flame retardants, blowing agents, impact modifiers and nucleating agents.
  • thermoplastic polymers used, for example, as additives are preferably not polyamides.
  • the mixture (M) contains, for example, in the range of 0, 1 to 20 wt .-%, preferably in the range of 0.2 to 10 wt .-% and particularly preferably in the range of 0.3 to 35 5 wt .-% of Additives, based on the total weight of the mixture (M).
  • the mixture (M) contains at least one lactam as component (A).
  • at least one lactam means both exactly one lactam and a mixture of two or more lactams.
  • the mixture (M) preferably contains exactly one lactam as component (A)
  • component (A) and “at least one lactam” are used synonymously and therefore have the same meaning.
  • lactam is preferably understood to mean cyclic amides which contain 4 to 12 carbon atoms, preferably 6 to 12 carbon atoms, in the ring.
  • the present invention thus also provides a process in which the component (A) contained in the mixture (M) is at least one lactam having 4 to 12 carbon atoms.
  • Suitable lactams are, for example, selected from the group consisting of butyro-4-lactam ( ⁇ -lactam; ⁇ -butyrolactam; pyrrolidone), 2-piperidone ( ⁇ -lactam, ⁇ -valerolactam, piperidone), hexano-6-lactam ( ⁇ - Lactam, ⁇ -caprolactam), heptano-7-lactam ( ⁇ -lactam, ⁇ -heptanolactam, enanthlactam), octano-8-lactam ( ⁇ -lactam, ⁇ -octanolactam, capryllactam), nonano-9-lactam ( ⁇ -lactam ⁇ -nonanolactam), decano-10-lactam ( ⁇ -decanolactam
  • the present invention thus also provides a process in which the component (A) contained in the mixture (M) is selected from the group consisting of pyrrolidone, piperidone, ⁇ -caprolactam, enanthlactam, capryllactam, caprinlactam and laurolactam.
  • the lactams may be unsubstituted or at least monosubstituted. In the event that at least monosubstituted lactams are used, they may carry one, two or more substituents on the carbon atoms of the ring, which are selected independently of one another from the group consisting of C to C 10 -alkyl, C 5 to C 6 - Cycloalkyl and C 5 - to C 10 -aryl.
  • component (A) is unsubstituted.
  • Suitable C 1 to C 10 -alkyl substituents are, for example, methyl, ethyl, propyl, isopropyl, n-butyl, sec-butyl and tert-butyl.
  • a suitable C 5 to C 6 cycloalkyl substituent is, for example, cyclohexyl.
  • Preferred C 5 to C 10 aryl substituents are phenyl and anthranyl.
  • Unsubstituted lactams are particularly preferably used, preference being given to 12-dodecane a lactam ( ⁇ -dodecanolactam) and ⁇ -lactam ( ⁇ -caprolactam). Most preferred is ⁇ -lactam ( ⁇ -caprolactam).
  • ⁇ -caprolactam is the cyclic amide of caproic acid. It is also referred to as 6-aminohexanoic acid lactam, 6-hexanlactam or caprolactam. Its lUPAC name is "Acepan-2- ⁇ .”
  • Caprolactam has CAS number 105-60-2 and the general formula CeHnNO. Methods for the preparation of caprolactam are known to those skilled in the art.
  • the component (A) contained in the mixture (M) usually has a melting temperature T M (A).
  • the melting temperature T M ⁇ A) of the component (A) contained in the mixture (M) is, for example, in the range of 20 to 250 ° C, preferably in the range of 50 to 200 ° C, and more preferably in the range of 70 to 160 ° C as determined by Differential Scanning Calorimetry (DSC).
  • the mixture (M) contains two or more lactams as component (A)
  • these two or more lactams may also have different melting temperatures T M ⁇ A).
  • the component (A) may then have two or more melting temperatures T M ⁇ A), wherein the two or more melting temperatures T M ⁇ A) then preferably all lie in the aforementioned ranges.
  • the mixture (M) contains at least one catalyst as component (B).
  • the mixture (M) preferably contains exactly one catalyst as component (B).
  • component (B) and “at least one catalyst” are used synonymously and therefore have the same meaning.
  • the at least one catalyst is preferably a catalyst for the anionic polymerization of a lactam. Therefore, the at least one catalyst preferably allows the formation of lactam ions. Thus, the at least one catalyst is capable of forming lactamates by cleaving off the nitrogen-bonded proton of the at least one lactam (component (A)).
  • Lactam anions per se may also act as the at least one catalyst.
  • the at least one catalyst may also be referred to as an initiator.
  • Suitable components (B) are known to those skilled in the art as such and for example in "polyamides. Kunststoff-Handbuch ", Carl-Hanser-Verlag 1998.
  • component (B) is selected from the group consisting of alkali metal lactamates, alkaline earth metal lactamates, alkali metals, alkaline earth metals, alkali metal hydrides, alkaline earth metal hydrides, alkali metal hydroxides, alkaline earth metal hydroxides, alkali metal alcoholates, alkaline earth metal alcoholates, alkali metal amides, alkaline earth metal amides, alkali metal oxides, alkaline earth metal oxides and organometallic compounds.
  • the present invention thus also provides a process in which the component (B) contained in the mixture (M) is selected from the group consisting of alkali metal lactamates, alkaline earth metal lactamates, alkali metals, alkaline earth metals, alkali metal hydrides, alkaline earth metal hydrides, alkali metal hydroxides, alkaline earth metal hydroxides, alkali metal alcoholates, alkaline earth metal alcoholates , Alkali metal amides, alkaline earth metal amides, alkali metal oxides, alkaline earth metal oxides and organometallic compounds.
  • Component (B) is particularly preferably selected from alkali metal lactamates and alkaline earth metal lactamates.
  • Alkali metal lactamates are known to those skilled in the art. Suitable alkali metal lactamates are, for example, sodium caprolactamate and potassium caprolactamate. Suitable alkaline earth metal lactamates are, for example, bromide magnesium caprolactamate, chloride magnesium caprolactamate and magnesium biscaprolactamate. Suitable alkali metals are, for example, sodium and potassium, Suitable alkaline earth metals are, for example, magnesium and calcium. Suitable alkali metal hydrides are, for example, sodium hydride and potassium hydride, and suitable alkali metal hydroxides are, for example, sodium hydroxide and potassium hydroxide. Examples of suitable alkali metal alcoholates are sodium methoxide, sodium ethanolate, sodium propanolate, sodium butoxide, potassium methoxide, potassium ethanolate, potassium propoxide and potassium butoxide.
  • component (B) is selected from the group consisting of sodium hydride, sodium, sodium caprolactamate and a solution of sodium caprolactamate in caprolactam.
  • Particularly preferred is sodium caprolactamate and / or a solution of sodium caprolactamate in caprolactam (for example, Brüggolen C10, 17 to 19% by weight of sodium caprolactamate and caprolactam).
  • the at least one catalyst can be used as a solid or in solution.
  • the at least one catalyst is used as a solid.
  • the catalyst is particularly preferably added to a caprolactam melt in which it can be dissolved.
  • component (B) is, for example, an alkali metal
  • component (A) it will react upon contact with the at least one lactam (component (A)) to form an alkali metal lactamate.
  • the mixture (M) contains according to the invention as component (C) at least one activator.
  • the mixture (M) preferably contains exactly one activator as component (C).
  • component (C) and “at least one activator” are used synonymously and therefore have the same meaning.
  • At least one activator is any activator known in the art, which is suitable for activating the anionic polymerization of the at least one lactam (component (A)).
  • Component (C) is preferably selected from the group consisting of carbodiimides, isocyanates, acid anhydrides, acid halides and their reaction products with component (A).
  • the present invention also provides a process in which the component (C) contained in the mixture (M) is selected from the group consisting of carbodiimides, isocyanates, acid anhydrides, acid halides and their reaction products with the component (A).
  • Suitable isocyanates are, for example, aliphatic diisocyanates such as butylene diisocyanate, hexamethylene diisocyanate, octamethylene diisocyanate,
  • Decamethylene diisocyanate, undecamethylene diisocyanate, dodecamethylene diisocyanate, 4,4-methylenebis (cyclohexyl isocyanate) and isophorone diisocyanate are also known under the name "Basonat HI 100" from BASF SE, likewise suitable are allophanates such as, for example, ethylallophanates.
  • Suitable acid halides are, for example, aliphatic diacid halides, such as butylene di-chloride, butylene di-bromide, hexamethylene diacid, hexamethylene diacid, octamethylene diacid, octamethylene diacid, decamethylene diacid, decamethylene diacid, dodecamethylene diacid chloride, dodecamethylene diacid, 4,4'-methylenebis (cyclohexylic chloride), 4,4'-methylene-bis ( Also suitable as acid halides are, for example, aromatic diacid halides, such as toluylmethylenedioic acid chloride, and cyclohexanoic acid bromide), isophorone diacid chloride and isophorone diacid bromide.
  • aromatic diacid halides such as toluylmethylenedioic acid chloride, and cyclohexanoic acid bromide
  • component (C) is selected from the group consisting of hexamethylene diisocyanate, isophorone diisocyanate, hexamethylene diacid bromide and hexamethylene diacid chloride. Most preferably, component (C) is hexamethylene diisocyanate.
  • the at least one activator with component (A), which contains at least one lactam forms an activated lactam in situ.
  • This forms activated N-substituted lactams such as acyl lactam.
  • the person skilled in the corresponding reactions are known.
  • the at least one activator can be used in bulk or in solution, preferably the at least one activator is dissolved in caprolactam.
  • At least one activator is therefore also Brüggolen C 20, 80% caprolactamblockiert.es 1, 6-hexamethylene diisocyanate in caprolactam from Brüggemann DE, suitable.
  • the mixture (M) contains as component (D) at least one oxazolidine derivative.
  • the mixture (M) preferably contains exactly one oxazolidine derivative as component (D. ).
  • oxazolidine derivative in the context of the present invention derived from oxazolidine compounds.
  • Oxazolidine is known in the art.
  • Oxazolidine is a heterocyclic saturated hydrocarbon compound having a five-membered ring containing a nitrogen atom (N atom) and an oxygen atom (O atom).
  • oxazolidine derivative therefore does not include a compound derived from oxazolidinone.
  • Oxazolidinone is also known to the person skilled in the art.
  • the term "oxazolidine derivative” therefore does not include a compound derived from oxazoline.
  • Oxazoline is known in the art.
  • Oxazoline is a heterocyclic unsaturated hydrocarbon compound having a five-membered ring containing a C-C double bond, a nitrogen atom and an oxygen atom.
  • the present invention therefore also provides a process in which component (D) does not comprise an oxazolidinone-derived compound.
  • the present invention further provides a process wherein component (D) does not comprise an oxazoline-derived compound.
  • component (D) and "at least one oxazolidine derivative” are used synonymously in the context of the present invention and therefore have the same meaning. Suitable components (D) are known to the person skilled in the art. According to the invention, preference is given to the at least one oxazolidine derivative (component (D)) selected from the group consisting of an oxazolidine derivative of the general formula (I)
  • R 1 , R 2 , R 3 , R 4 , R 5 , R 6 and R 7 are independently selected from the group consisting of hydrogen, unsubstituted or at least monosubstituted C-
  • R a , R b and R c are independently selected from the group consisting of hydrogen and unsubstituted Ci-Ci 0 alkyl; and an oxazolidine derivative of the general formula (II)
  • R 8 and R 8 ' are independently selected from the group consisting of unsubstituted or at least monosubstituted CiCi o-alkanediyl, wherein the substituents are selected from the group consisting of Ci-Ci 0 alkyl;
  • R 9 , R 9 ' , R 10 , R 10' , R 11 , R 11 ' , R 12 , R 12' , R 13 , R 13 ' , R 14 and R 14' are independently selected from the group consisting of Hydrogen, unsubstituted or at least monosubstituted C 1 -C 30 -alkyl and unsubstituted or at least monosubstituted C 5 -C 30 -aryl, where the substituents are selected from the group consisting of NR d R e , OR f , d-d-alkyl, C 5 -C 10 -aryl, F, Cl and Br, wherein R d , R e and R f are independently selected from the group consisting of hydrogen and unsubstituted C "iC 10 alkyl.
  • the present invention thus also provides a process in which the at least one oxazolidine derivative (component (D)) is selected from the group consisting of an oxazolidine derivative of the general formula (I)
  • R 1 , R 2 , R 3 , R 4 , R 5 , R 6 and R 7 are independently selected from the group consisting of hydrogen, unsubstituted or at least monosubstituted C-
  • R a , R b and R c are independently selected from the group consisting of hydrogen and unsubstituted Ci-Ci 0 -alkyl, and an oxazolidine derivative of the general formula (II)
  • R 8 and R 8 ' are independently selected from the group consisting of unsubstituted or at least monosubstituted C 1 -C 10 -alkanediyl, where the substituents are selected from the group consisting of d-dicarboxylic
  • R 9 , R 9 ' , R 10 , R 10' , R 11 , R 11 ' , R 12 , R 12' , R 13 , R 13 ' , R 14 and R 14' are independently selected from the group consisting of hydrogen, unsubstituted or at least mono-CiC o-3 alkyl, and unsubstituted or at least mono-substituted C 5 -C 3 -aryl, wherein the substituents are selected from the group consisting of NR d R e,
  • oxazolidine derivative of general formula (I) is also referred to in the context of the present invention as "oxazolidine derivative (I)", the oxazolidine derivative of general formula (II) in the context of the present invention also as “oxazolidine derivative (II) ".
  • oxazolidine derivative of the general formula (I) and “oxazolidine derivative (I)” are therefore used synonymously and have the same meaning.
  • oxazolidine derivative of the general formula (II) and “oxazolidine derivative (II)” are used synonymously and also have the same meaning.
  • the substituents in the at least one oxazolidine derivative (I) have the following meaning: R 1 , R 2 and R 3 are independently selected from the group consisting of hydrogen and unsubstituted or at least monosubstituted C 1 - C 2 o-alkyl, wherein the substituents are selected from the group consisting of NR a R b , OR c and d-do-alkyl, wherein
  • R a , R b and R c are independently selected from the group consisting of hydrogen and unsubstituted C 1 -C 5 alkyl;
  • R 4 , R 5 , R 6 and R 7 are independently selected from the group consisting of hydrogen, unsubstituted C 1 -C 2 o-alkyl and unsubstituted C 5 -C 2 o-aryl.
  • the substituents of the at least one oxazolidine derivative (I) have the following meaning:
  • R 1 , R 2 and R 3 are independently selected from the group consisting of hydrogen and unsubstituted or at least monosubstituted C 1 -C 2 o-alkyl, wherein the substituents are selected from the group consisting of NH 2 , OH and CC 5 alkyl;
  • R 4 and R 6 are hydrogen
  • R 5 and R 7 are independently selected from the group consisting of hydrogen and unsubstituted C 1 -C 2 o-alkyl.
  • the substituents of the at least one oxazolidine derivative (I) have the following meaning:
  • R 1 is selected from the group consisting of hydrogen and unsubstituted C 1 -C 2 o-alkyl
  • R 2 is selected from the group consisting of hydrogen and unsubstituted or at least monosubstituted C 1 -C 2 o-alkyl, wherein the substituents are selected consisting of the group
  • R 3 , R 4 , R 5 , R 6 and R 7 are each hydrogen.
  • the substituents of the at least one oxazolidine derivative (I) have the following meaning:
  • R 1 is selected from the group consisting of hydrogen and unsubstituted C 1 -C 4 -alkyl
  • R 2 is selected from the group consisting of hydrogen and unsubstituted or at least monosubstituted C 1 -C 6 -alkyl, wherein the substituents are selected from the group consisting of CC 5 alkyl;
  • R 3 , R 4 , R 5 , R 6 and R 7 are each hydrogen.
  • the substituents of the oxazolidine derivative (II) have the following meaning: R 8 and R 8 ' are independently selected from the group consisting of unsubstituted or at least monosubstituted CiC-io-alkanediyl, wherein the substituents are selected from the group consisting of Ci-Cio-alkyl;
  • R 9 , R 9 ' , R 10 , R 10' are independently selected from the group consisting of hydrogen, unsubstituted or at least monosubstituted C 1 -C 2 o-alkyl and unsubstituted or at least monosubstituted C 5 -C 2 o-aryl,
  • substituents are selected from the group consisting of Ci-Ci 0 -alkyl
  • R 11 , R 11 ' , R 12 , R 12' , R 13 , R 13 ' , R 14 and R 14' are independently selected from the group consisting of hydrogen, unsubstituted C 1 -C 2 o-alkyl and unsubstituted C 5 -C 2 o-aryl.
  • R 8 and R 8 ' are independently selected from the group consisting of unsubstituted CiC-io-alkanediyl;
  • R 9 , R 9 ' , R 10 , R 10' are independently selected from the group consisting of hydrogen, unsubstituted or at least monosubstituted Ci-Ci 0- alkyl, wherein the substituents are selected from the group consisting of Ci-Cs-alkyl ;
  • R 11 , R 11 ' , R 13 and R 13' are hydrogen;
  • R 12 , R 12 ' , R 14 and R 14' are independently selected from the group consisting of hydrogen, unsubstituted C 1 -C 2 o-alkyl and unsubstituted Cs-CarAryl.
  • the substituents of the oxazolidine derivative (II) have the following meaning: R 8 and R 8 'are independently selected from the group consisting of unsubstituted C-
  • R 11 , R 11 ' , R 12 , R 12' , R 13 , R 13 ' , R 14 and R 14' are hydrogen.
  • the substituents of the oxazolidine derivative (II) have the following meaning:
  • R 8 and R 8 ' are identical and are selected from the group consisting of unsubstituted C-
  • R 9 and R 9 ' are the same and selected from the group consisting of hydrogen, unsubstituted or at least monosubstituted C 1 -C 5 -alkyl, where the substituents are selected from the group consisting of C 1 -C 5 -alkyl;
  • R 10 , R 10 ' , R 11 , R 11' , R 12 , R 12 ' , R 13 , R 13' , R 14 and R 14 ' are hydrogen.
  • the at least one oxazolidine derivative (component (D)) is an oxazolidine derivative (I), wherein for the oxazolidine derivative (I) the previously described embodiments and preferences apply.
  • the at least one oxazolidine derivative (component (D)) selected from the group consisting of 3- (1, 3-oxazolidine) ethanol-2- (1-methylethyl) -3,3'-carbonate and 3-butyl -2- (1-ethylpentyl) -1,3-oxazolidine, most preferably the at least one oxazolidine derivative (component (D)) is 3-butyl-2- (1-ethylpentyl) -1,3-oxazolidine.
  • the present invention therefore also provides a process in which the at least one oxazolidine derivative (component (D)) is selected from the group consisting of 3- (1,3-oxazolidine) ethanol-2- (1-methylethyl) -3,3'-carbonate and 3-butyl-2- (1-ethylpentyl) -1,3-oxazolidine.
  • CiC o-3 alkyl refers to saturated and unsaturated, preferably saturated hydrocarbons having a free valence (radical) and from 1 to 30 carbon atoms.
  • the hydrocarbons may be linear or cyclic. It is also possible that they contain a cyclic and a linear component. Examples of such alkyl groups are methyl, ethyl, n-propyl, n-butyl, hexyl and cyclohexyl.
  • Corresponding statements also apply to C 1 -C 2 o-alkyl and C 1 -C 10 -alkyl, C 1 -C 5 -alkyl, C 4 -alkyl and CC 6 -alkyl.
  • C 5 -C 3 o-Aryl refers to the radical of an aromatic hydrocarbon having from 5 to 20 carbon atoms, ie, an aryl has an aromatic ring system, which may be monocyclic, bicyclic, or polycyclic Examples of aryl groups include phenyl and naphthyl, such as 1-naphthyl and 2-naphthyl The corresponding statements also apply to C 5 -C 2 o-aryl.
  • C 1 -C 10 -alkanediyl denotes a hydrocarbon having 1 to 10 carbon atoms and two free valences, ie a biradical having 1 to 10 carbon atoms.
  • C 1 -C 10 -alkanediyl includes both linear and also cyclic and saturated and unsaturated hydrocarbons having 1 to 10 carbon atoms and two free valencies.
  • Hydrocarbons having a linear and a cyclic fraction likewise fall under the term "C 1 -C 10 -alkanediyl.”
  • C 1 -C 10 -alkanediyl are methylene, ethylene (ethane-1, 2-diyl, dimethylene), propane-1,3 -diyl (trimethylene), propylene (propane-1, 2-diyl) and butane-1, 4-diyl (tetramethylene).
  • d-Cs-alkanediyl are methylene, ethylene (ethane-1, 2-diyl, dimethylene), propane-1,3 -diyl (trimethylene), propylene (propane-1, 2-diyl) and butane-1, 4-diyl (tetramethylene).
  • the mixture (M) is reacted.
  • the mixture (M) can be reacted by all methods known to those skilled in the art.
  • the reaction of the mixture (M) can be carried out in all reactors known to those skilled in the art, which are suitable at the temperatures at which the Mixture (M) is reacted to be used.
  • the mixture (M) is reacted in a mold.
  • the mixture (M) can be introduced, for example by injection or pouring.
  • injection all methods known to those skilled in the art are suitable.
  • the mixture is introduced into the mold, for example by injection or pouring, it is usually introduced into the mold in liquid form.
  • the mixture (M) is usually introduced into the mold in liquid form.
  • the components (A) to (D) and optionally the at least one filler and the additives can be introduced together into the reactor, preferably into the mold. It is likewise possible to introduce them separately into the reactor, preferably into the mold.
  • the components (A) to (D) are introduced separately into the mold. Then, introducing the components (A) to (D) into the reactor comprises, for example, the following steps: a) providing a first mixture (M1) containing the components
  • introduction of components (A) to (D) into the reactor comprises, for example, the following steps: a) providing a first mixture (M1) containing the components (A) at least one lactam,
  • (D) contains at least one oxazolidine derivative, c) mixing the first mixture (M1) with the second mixture (M2) to obtain the mixture (M).
  • the first mixture (M1) and the second mixture (M2) can be provided in each case by all methods known to the person skilled in the art.
  • the mixing of the first mixture (M1) with the second mixture (M2) can be carried out by all methods known to the person skilled in the art.
  • the first mixture (M1) and the second mixture (M2) may be directly mixed in the mold to give the mixture (M).
  • the first mixture (M1) and the second mixture (M2) are mixed in a suitable mixing device to obtain the mixture (M), which is then subsequently introduced into the mold.
  • the mixture (M) is prepared and subsequently introduced into the mold.
  • Suitable mixing devices are known to the person skilled in the art and, for example, static and / or dynamic mixers.
  • the reaction of the mixture (M) can be carried out at any temperature T. It is preferably carried out above the melting temperature T M ⁇ A ) of the component (A) contained in the mixture (M). If two or more lactams are used as component (A), the reaction of the mixture (M) is preferably carried out at a temperature T which is above the melting temperature T M ⁇ A ) of the lactam, which has the highest melting temperature T M ⁇ A ) ,
  • the reaction of the mixture (M) thus takes place at a temperature T, which is greater than the melting temperature T M ⁇ A ) of the component (A).
  • the present invention thus also provides a process in which the component (A) contained in the mixture (M) has a melting temperature T M ⁇ A ) and the reaction of the mixture (M) takes place at a temperature T which is greater than the melting temperature T M ⁇ A ) of the component (A).
  • the component (A) is therefore preferably molten and therefore liquid.
  • the other components (B), (C) and (D) present in the mixture (M) and, if appropriate, the additives may then likewise be melted and therefore liquid, and it is also possible that they are present dissolved in component (A).
  • the optionally present in the mixture (M) at least one filler usually does not dissolve in the mixture (M) and usually is not present in molten form. Contains the mixture (M) the at least one filler, then this is during the reaction of the mixture (M) usually dispersed in the preferably molten present component (A) before.
  • the at least one filler then forms the disperse phase (dispersed phase), the component (A) and optionally the components (B), (C), (D) and the additives the dispersion medium (the continuous phase).
  • the polyamide produced by the process of this invention has a melting temperature T M ⁇ P) (P), and reacting the mixture (M) at a temperature T which is less than the melting temperature T M ⁇ P) of the polyamide (P), takes place.
  • the subject matter of the present invention is thus also a process in which the polyamide (P) has a melting temperature T M ⁇ P ) and the reaction of the mixture (M) at a temperature T which is less than the melting temperature T M ⁇ P ) Polyamide (P), takes place.
  • the "melting temperature T M ⁇ P ) of the polyamide (P)" is understood to be the melting temperature of the polyamide (P) prepared by the process according to the invention.
  • the temperature T in the reaction of the mixture (M) is in the range of 50 to 250 ° C, preferably in the range of 80 to 200 ° C and particularly preferably in the range of 100 to 180 ° C. It is particularly preferred that the temperature T in the reaction of the mixture (M) below the melting temperature T M ⁇ P ) of the polyamide (P). The temperature T in the reaction of the mixture (M) is therefore preferably smaller than the melting temperature T M ⁇ P ) of the polyamide (P).
  • the crystallinity of the polyamide (P) is usually in the range of 10% to 70%, preferably in the range of 20% to 60% and more preferably in the range of 25% to 45%, determined by differential scanning calorimetry (DSC).
  • DSC differential scanning calorimetry
  • the melting temperature T M ⁇ P ) of the obtained polyamide (P) is, for example, in the range of> 160 to 280 ° C, preferably in the range of 180 to 250 ° C and particularly preferably in the range of 200 to 230 ° C.
  • the glass transition temperature of the resulting polyamide (P) is, for example, in the range of 20 to 150 ° C, preferably in the range of 30 to 1 10 ° C, and particularly preferably in the range of 40 to 80 ° C.
  • the melting temperature T M ⁇ P ) and the glass transition temperature of the obtained polyamide (P) are determined by means of differential scanning calorimetry (DSC). Processes for this are known to the person skilled in the art.
  • the proportion of unreacted component (A) in the obtained polyamide (P) is usually in the range of 0.01 to 6 wt .-%, preferably in the range of 0, 1 to 3 wt .-% and particularly preferably in the range of 1 to 2 wt .-%, each based on the total weight of the resulting polyamide (P).
  • the viscosity number of the resulting polyamide (P) is usually in the range of 50 to 1000, preferably in the range of 200 to 800 and more preferably in the range of 400 to 750, determined with 96% sulfuric acid as a solvent at a temperature of 25 ° C. a DI N Ubbelohde I l capillary.
  • the present invention therefore also provides a polyamide (P) obtainable by the process according to the invention.
  • the crystallization rate of the polyamide (P) is increased by the use of an oxazolidine derivative in a polyamide.
  • the present invention thus also relates to the use of an oxazolidine derivative in a polyamide (P) for increasing the crystallization rate of the polyamide (P).
  • the previously described embodiments and preferences for the at least one oxazolidine derivative (component (D)) present in the mixture (M) apply correspondingly.
  • the crystallization rate of the polyamide (P) is determined according to the invention as follows: The time at which the mixture (M) is ready and the temperature of the mixture (M) is at the temperature T at which the reaction of the mixture (M) takes place as the starting time t s tart.
  • the starting time t S tart indicates the time from which the time until crystal formation is measured.
  • the time of crystal formation is determined optically.
  • the mixture (M) is reacted from the starting time t S t a rt.
  • the reaction of the mixture (M) is exothermic, so in the implementation of energy is released and the temperature T increases. It forms the polyamide (P). As soon as a turbidity of the mixture (M) is recognizable, the time is stopped.
  • the time that elapses between the start time t S t a rt and the cloudiness of the mixture (M) is then the time to crystal formation of the polyamide (P). From it can be concluded on the crystallization rate. It is also possible that at the beginning of the turbidity of the mixture (M) formed polyamide and / or oligomers thereof fail and contribute to the turbidity of the mixture (M).
  • the mixture (M) according to the invention can be used for producing a molded article from the polyamide (P). Processes for this are known to the person skilled in the art.
  • the mixture (M) according to the invention the demoulding time of the shaped body is reduced.
  • the present invention therefore also relates to the use of an oxazolidine derivative in a polyamide (P) for the production of a shaped article from the polyamide (P) in order to reduce the demoulding time of the shaped article.
  • the previously described embodiments and preferences for the at least one oxazolidine derivative (component (D)) present in the mixture (M) apply correspondingly.
  • the demoulding time of the molded article is determined as follows: The mixture (M) is reacted at a temperature T. At a time t EntS tart the polyamide (P) produced in the implementation of the mixture (M) begins to dissolve from the wall of the reactor and shrinks. This time t EntS tart is the beginning of the measurement. Once that in the implementation of the mixture (M) produced Polyamide (P) no longer shrinks, the time t EntE Nde is reached and the measurement is terminated. The demolding time then corresponds to the time that elapses between the time t en tstart and the time t EntEnde . The time t Entende is also referred to as demolding time. The demolding time is also referred to as shrinkage time.
  • the oxazolidine derivative according to the invention can moreover be prepared in a reaction mixture (RM) which contains the components (A) at least one lactam,
  • the present invention therefore also provides the use of an oxazolidine derivative in a reaction mixture (RM) containing the components
  • the reaction mixture (RM) contains, for example, in the range of 0.01 to 5000 ppm of component (E), preferably in the range of 0.1 to 1000 ppm of component (E) and particularly preferably in the range of 1 to 700 ppm of component (E). E), in each case based on the total weight of the reaction mixture (RM).
  • the sum of the percentages by weight of the components (A) to (E) contained in the reaction mixture (RM) usually adds up to 100%.
  • the oxazolidine derivative the previously described embodiments and preferences for the at least one oxazolidine derivative (component (D)) present in the mixture (M) apply correspondingly.
  • the object is also the use according to the invention, wherein the at least one oxazolidine derivative is selected from the group consisting of an oxazolidine derivative of the general formula (I)
  • R 1 , R 2 , R 3 , R 4 , R 5 , R 6 and R 7 are independently selected from the group consisting of hydrogen, unsubstituted or at least monosubstituted C-
  • R a , R b and R c are independently selected from the group consisting of hydrogen and unsubstituted Ci-Ci 0 alkyl , and an oxazolidine derivative of the general formula (II)
  • R 8 and R 8 ' are independently selected from the group consisting of unsubstituted or at least mono-CiC-io-alkanediyl, wherein the substituents are selected from the group consisting of C1-C1 0 - alkyl;
  • R 9 , R 9 ' , R 10 , R 10' , R 11 , R 11 ' , R 12 , R 12' , R 13 , R 13 ' , R 14 and R 14' are independently selected from the group consisting of hydrogen, unsubstituted or at least mono-substituted Ci-C 30 alkyl, and unsubstituted or at least mono-substituted C 5 -C 3 -aryl, wherein the substituents are selected from the group consisting of NR d R e, oR f, d-do-alkyl, C 5 -C 10 aryl, F, Cl and Br, wherein
  • R d , R e and R f are independently selected from the group consisting of hydrogen and unsubstituted C "iC 10 alkyl.
  • Incozole 2 (3-butyl-2- (1-ethylpentyl) -1,3-oxazolidine) (Incorez Ltd, Miller Street, Preston, Lancashire, PR1 1 EA, England)
  • Incozole LV (3- (1,3-oxazolidine) ethanol-2- (1-methylethyl) -3,3'-carbonate) (Incorez Ltd, Miller Street, Preston, Lancashire, PR1 1 EA, England)
  • Dry caprolactam having a water content of ⁇ 30 ppm and incozole 2 were heated to 140 ° C. in the amounts indicated in Table 1. After adding the catalyst in the amounts shown in Table 1 and again reaching the reaction temperature, the polymerization was started by adding the activator (Brüggolen C20) in the amounts shown in Table 1. After 15 minutes, the polymerization was quenched by cooling the reaction vessel in ice-water (0 ° C). Table 1
  • Examples B8 to B12 Dry caprolactam having a water content of ⁇ 30 ppm and Incozol LV were heated to 140 ° C. in the amounts indicated in Table 2. After addition of the catalyst (Brüggolen C10) in the amounts shown in Table 2 and again reaching the reaction temperature, the polymerization was started by adding the activator (Brüggolen C20) in the amounts indicated in Table 2. After 15 minutes, the polymerization was quenched by cooling the reaction vessel in ice-water (0 ° C).
  • Caprolactam having a water content of 350 ppm and incozole 2 were heated to 140 ° C. in the amounts indicated in Table 3. After addition of the catalyst (Brüggolen C10) in the amounts shown in Table 3 and again reaching the reaction temperature, the polymerization was started by adding the activator (Brüggolen C20) in the amounts indicated in Table 3. After 15 minutes, the polymerization was quenched by cooling the reaction vessel in ice-water (0 ° C).
  • Caprolactam having a water content of 700 ppm and Incozol 2 were heated to 140 ° C. in the amounts indicated in Table 4. After addition of the catalyst in the amounts shown in Table 4 and again reaching the reaction temperature, the polymerization was started by adding the activator (Brüggolen C20) in the amounts indicated in Table 4. After 15 minutes, the polymerization was quenched by cooling the reaction vessel in ice water (0 ° C).
  • the activator Brüggolen C20
  • Caprolactam with a water content of 530 ppm and Incozol LV were heated to 140 ° C. in the amounts indicated in Table 5. After addition of the catalyst in the amounts shown in Table 5 and again reaching the reaction temperature, the polymerization was started by adding the activator (Brüggolen C20) in the amounts indicated in Table 5. After 15 minutes, the polymerization was quenched by cooling the reaction vessel in ice-water (0 ° C).
  • FIG. 1 to 6 show the results for the various examples.
  • FIG. 1 a shows the influence of incozole 2 as oxazolidine derivative on the reactivity of the mixture (M).
  • FIG. 1 b shows the influence of Incozol LV as oxazolidine derivative on the reactivity of the mixture (M).
  • the time t is given in seconds (s) on the x-axes, and the temperature T in ° C is indicated on the y-axes.
  • the reaction of the mixture (M) is exothermic. So it will be during the implementation of Mixture (M) releases energy and the mixture (M) heats up during the reaction.
  • the temperature T of the mixture (M) was measured as a function of time t.
  • the starting time t S tart (0 s) was the time at which the mixture (M) was ready and its temperature T was 5 140 ° C.
  • FIG. 1 b shows the reactivity of the mixture (M) is similar to the reactivity of the mixture without the addition of Incozol LV as oxazolidine derivative (Comparative Example V1).
  • the reaction is also similar to exothermic as the reaction of the mixture without Incozol LV as oxazolidine derivative.
  • FIG. 2a shows the time to crystal formation as a function of the amount of incozole 2 contained in the mixture (M) as the oxazolidine derivative.
  • the x-axis indicates the amount of incozole 2 contained in the mixture (M) in mol%
  • the y-axis shows the time t in seconds (s) between providing the mixture (M) at 140 ° C and Recognizing a turbidity of the mixture (M).
  • Figure 2b shows the time to crystal formation depending on the amount of incozole LV contained in the mixture (M) as the oxazolidine derivative.
  • the x-axis indicates the amount of incozole LV contained in the mixture (M) in mol.%
  • the y-axis shows the time t in seconds (s) between the preparation of the mixture (M) at 140 ° C and Recognizing a turbidity of the mixture (M). It can be seen from FIG. 2 b that with an increasing proportion of incozole LV as the oxazolidine derivative, the time until the onset of turbidity and thus also until the onset of crystal formation is likewise markedly reduced.
  • FIG. 3 a shows the demolding time for different contents of incozole 2 as oxazolidine derivative in the mixture (M).
  • the x-axis indicates the proportion of oxazolidine derivative in the mixture (M) in mol%
  • the y-axis indicates the time t in minutes (min).
  • tart ENTs in which the polyamide prepared (M) in the reaction of the mixture (P) begins to separate from the wall of the reactor.
  • the point in time t is reached.
  • the times t en tstart and t ends are indicated in FIG. 3 a as a function of the incozole 2 fraction. The difference between the two times corresponds to the demolding time. It can be seen that the demolding time is reduced by the oxazolidone derivative.
  • Figure 3b shows the demolding time for various levels of incozole LV as the oxazolidine derivative in the mixture (M).
  • the x-axis indicates the proportion of oxazolidine derivative in the mixture (M) in mol%
  • the y-axis indicates the time t in minutes (min).
  • the time t EntS tart was determined at which the polyamide prepared in the reaction of the mixture (M) (P) begins to dissolve from the wall of the reactor. As soon as the polyamide (P) produced during the reaction of the mixture (M) no longer shrinks, the point in time t is reached.
  • the times t en tstart and t Entende are indicated in Figure 3b as a function of the Incozol LV share.
  • FIGs 4 and 5 show how the reactivity of a reaction mixture (RM) containing 350 ppm ( Figure 4) and 700 ppm (Figure 5) water changes by the presence of incozole 2 as the oxazolidine derivative.
  • the x-axes respectively show the time t in seconds (s), the y-axes show the temperature T of the reaction mixture (RM).
  • Figure 6 shows how the reactivity of a reaction mixture (RM) containing 530 ppm of water changes by the presence of Incozol LV as the oxazolidine derivative.
  • the x-axis shows the time t in seconds (s), the y-axis shows the temperature T of the reaction mixture (RM). From the slope of the curves, it can be seen that the reactivity is highest with the use of dry caprolactam (Comparative Example C1), while it is lowest with the use of caprolactam having a water content of 530 ppm (Comparative Example V27).
  • FIG. 7 shows the residual content of caprolactam (proportion of unreacted component (A)) in the polyamide (P) produced as a function of the amount of incozole 2 used as oxazolidine derivative for different proportions of water in the caprolactam used (component (A)). ).
  • the x-axis indicates the amount of oxazolidine derivative used in mol%
  • the y-axis the residual content of caprolactam in wt .-%, based on the total weight of the polyamide (P). It can be seen that with increasing proportion of oxazolidine derivative, the residual content of caprolactam can be reduced.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Polyamides (AREA)
  • Polymerization Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

L'invention concerne un procédé pour produire un polyamide (P) en faisant réagir un mélange (M) contenant au moins un lactame (composant (A)), au moins un catalyseur (composant (B)), au moins un activateur (composant (C)) et au moins un dérivé d'oxazolidine (composant (D)). L'invention concerne en outre le mélange (M) ainsi que l'utilisation d'un dérivé d'oxazolidine pour améliorer la vitesse de cristallisation d'un polyamide (P). L'invention concerne de plus l'utilisation d'un dérivé d'oxazolidine dans un polyamide (P) pour produire un corps moulé à partir du polyamide (P) afin de réduire le temps de démoulage du corps moulé. Elle concerne également l'utilisation d'un dérivé d'oxazolidine pour éliminer l'eau d'un mélange réactionnel (RM).
EP16762808.0A 2015-09-16 2016-09-07 Polymération anionique de lactames Withdrawn EP3350248A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15185507 2015-09-16
PCT/EP2016/071111 WO2017045988A1 (fr) 2015-09-16 2016-09-07 Polymération anionique de lactames

Publications (1)

Publication Number Publication Date
EP3350248A1 true EP3350248A1 (fr) 2018-07-25

Family

ID=54199530

Family Applications (1)

Application Number Title Priority Date Filing Date
EP16762808.0A Withdrawn EP3350248A1 (fr) 2015-09-16 2016-09-07 Polymération anionique de lactames

Country Status (6)

Country Link
US (1) US20190085127A1 (fr)
EP (1) EP3350248A1 (fr)
JP (1) JP2018530647A (fr)
KR (1) KR20180054708A (fr)
CN (1) CN108350169A (fr)
WO (1) WO2017045988A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3235861A1 (fr) * 2016-04-18 2017-10-25 LANXESS Deutschland GmbH Composition polymérisable
WO2017190989A1 (fr) 2016-05-04 2017-11-09 Basf Se Matériau composite auto-refroidissant contenant de la mousse
JP7005525B2 (ja) 2016-05-25 2022-02-10 ビーエーエスエフ ソシエタス・ヨーロピア 繊維強化発泡体の変換
CN109196031B (zh) 2016-05-25 2022-01-28 巴斯夫欧洲公司 通过模塑发泡法制得的纤维增强的反应性泡沫
US11787093B2 (en) 2016-08-26 2023-10-17 BASF SE (Ellwanger & Baier Patentanwälte) Process and tool for continuous production of fiber-reinforced foams
KR102652697B1 (ko) 2017-03-20 2024-03-28 바스프 에스이 금속 및 폴리아미드 조성물을 함유하는 라미네이트
KR102384315B1 (ko) * 2019-11-25 2022-04-07 재단법인 한국탄소산업진흥원 열가소성수지 기반 열전도성 마스터배치의 제조방법 및 그를 이용한 방열복합소재
FR3139164B1 (fr) 2022-08-26 2024-08-23 Nexans Colliers de serrage résistants au feu

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH427276A (de) * 1964-05-06 1966-12-31 Inventa Ag Verfahren zur Polymerisation höhergliedriger Lactame
CH499565A (de) * 1968-10-09 1970-11-30 Inventa Ag Verfahren zur Regulierung der Polymerisationsgeschwindigkeit der anionischen Polymerisation von Lactamen
DE1905099A1 (de) * 1969-02-01 1970-08-06 Bayer Ag Modifizierte Polyamide mit erhoehter Affinitaet gegenueber sauren Farbstoffen
DE19603305C2 (de) * 1996-01-25 1999-07-22 Inventa Ag Flüssiges Mehrkomponentensystem zur Durchführung der anionischen Lactampolymerisation
KR100480208B1 (ko) * 1999-03-26 2005-03-30 아토피나 락탐의 음이온성 중합 방법

Also Published As

Publication number Publication date
US20190085127A1 (en) 2019-03-21
JP2018530647A (ja) 2018-10-18
KR20180054708A (ko) 2018-05-24
CN108350169A (zh) 2018-07-31
WO2017045988A1 (fr) 2017-03-23

Similar Documents

Publication Publication Date Title
WO2017045988A1 (fr) Polymération anionique de lactames
EP2789641B1 (fr) Procédé de fabrication de compositions monomères et leur utilisation destinée à fabriquer un élément de formage en polyamide
EP2093246B1 (fr) Polymérisation anionique de lactames en utilisant des agents d'activation spéciaux
EP3320022B1 (fr) Procede de fabrication d'un polyamide
EP2729515A1 (fr) Particules solides, contenant un lactame, un activateur et un catalyseur, ainsi que procédé pour la production et l'utilisation desdites particules solides
EP2852628B1 (fr) Polyamide coulé, son procédé de fabrication et dýutilisation
DE102010040027A1 (de) Verfahren zur Herstellung von faserverstärkten Gusspolyamid-Formkörpern
EP2801587A1 (fr) Compositions, leur fabrication et leur utilisation pour la fabrication de polyamides de fonte
WO2013045319A1 (fr) Procédé de production de polyamides par polymérisation anionique
EP2870191B1 (fr) Catalyseurs pour la fabrication de polyamide de fusion, son procédé de fabrication et son utilisation
WO2018041642A1 (fr) Procédé pour la préparation d'un polyamide à l'aide de lactamate de potassium
EP0099058B1 (fr) Procédé pour la fabrication de corps moulés en polyamide à faible retrait
WO2016180832A1 (fr) Formulations de caprolactame
DE3043114A1 (de) Verfahren zur herstellung eines blockcopolyamids
DE68916977T2 (de) Verfahren zur Herstellung modifizierter Polyamide und so erhaltene Produkte.
EP2646494A2 (fr) Polyamides à réticulation transversale
WO2013144132A1 (fr) Procédé de fabrication de corps moulés en polyamide à partir d'une composition polymérisable au moyen d'un procédé de rotomoulage
DE19961818C2 (de) Flüssiginitiator zur beschleunigten Durchführung der anionischen Lactampolymerisation, Verfahren zu dessen Herstellung und Verwendung
EP2748229A1 (fr) Procédé de production de corps moulés
EP2748228A1 (fr) Procédé de production de corps moulés
DE68910407T2 (de) Verfahren zur Herstellung von modifizierten schlagfesten Polyamiden.
EP2530074B1 (fr) Nouvelle composition pour la fabrication de polyamides de fonte
DE1203467B (de) Verfahren zum Beschleunigen der anionischen Polymerisation von Lactamen
DE202012013160U1 (de) Katalysatoren für die Herstellung von Gusspolyamid
WO2003087193A1 (fr) Polyamides intrinsequement reticulables

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20180416

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20190828

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20200108